Cerecor Inc.

2.51-0.0900-3.46%Vol 407.99K1Y Perf -5.26%
Apr 16th, 2021 16:00 DELAYED
BID2.41 ASK2.58
Open2.63 Previous Close2.60
Pre-Market- After-Market2.51
 - -  - -%
Target Price
9.00 
Analyst Rating
Moderate Buy 1.67
Potential %
258.57 
Finscreener Ranking
★★+ —    -
Insiders Trans % 3/6/12 mo.
-/100/100 
Value Ranking
     42.98
Insiders Value % 3/6/12 mo.
-/100/100 
Growth Ranking
★★     45.17
Insiders Shares Cnt. % 3/6/12 mo.
-/100/100 
Income Ranking
 —    -
Market Cap223.65M 
Earnings Rating
Neutral
Price Range Ratio 52W %
21.34 
Earnings Date
6th May 2021

Today's Price Range

2.412.63

52W Range

1.974.50

5 Year PE Ratio Range

-54.50-1.10

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-10.68%
1 Month
-25.96%
3 Months
-7.38%
6 Months
4.15%
1 Year
-5.26%
3 Years
-28.08%
5 Years
-31.23%
10 Years
-

TickerPriceChg.Chg.%
CERC2.51-0.0900-3.46
AAPL134.16-0.3400-0.25
GOOG2 297.761.10000.05
MSFT260.741.24000.48
XOM56.66-0.3200-0.56
WFC43.841.60003.79
JNJ162.241.85001.15
FB306.18-1.6400-0.53
GE13.39-0.1600-1.18
JPM153.301.13000.74
Financial StrengthValueIndustryS&P 500US Markets
1.50
1.70
0.05
0.02
-
Leverage Ratio 1.50
ProfitabilityValueIndustryS&P 500US Markets
95.50
-634.20
-601.00
-567.40
-
RevenueValueIndustryS&P 500US Markets
3.94M
0.04
-43.35
-
Earnings HistoryEstimateReportedSurprise %
Q03 2020-0.10-0.16-60.00
Q02 2020-0.10-0.15-50.00
Q01 2020-0.12-0.0466.67
Q03 2019-0.17-0.0758.82
Q02 2019-0.16-0.1318.75
Q01 2019-0.16-0.1318.75
Q03 2018-0.12-0.26-116.67
Q02 2018-0.10-0.100.00
Earnings Per EndEstimateRevision %Trend
3/2021 QR-0.17-21.43Negative
6/2021 QR-0.18-20.00Negative
12/2021 FY-0.62-37.78Negative
12/2022 FY-0.0978.57Positive
Next Report Date6th May 2021
Estimated EPS Next Report-0.17
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume407.99K
Shares Outstanding89.11M
Trades Count2.87K
Dollar Volume2.02M
Avg. Volume947.24K
Avg. Weekly Volume524.61K
Avg. Monthly Volume475.99K
Avg. Quarterly Volume815.29K

Cerecor Inc. (NASDAQ: CERC) stock closed at 2.51 per share at the end of the most recent trading day (a -3.46% change compared to the prior day closing price) with a volume of 409.19K shares and market capitalization of 223.65M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 18 people. Cerecor Inc. CEO is Michael F. Cola.

The one-year performance of Cerecor Inc. stock is -5.26%, while year-to-date (YTD) performance is -4.92%. CERC stock has a five-year performance of -31.23%. Its 52-week range is between 1.97 and 4.5, which gives CERC stock a 52-week price range ratio of 21.34%

Cerecor Inc. currently has a PE ratio of -3.40, a price-to-book (PB) ratio of 10.93, a price-to-sale (PS) ratio of 61.44, a price to cashflow ratio of 7.40, a PEG ratio of 2.32, a ROA of -138.77%, a ROC of -122.33% and a ROE of -243.11%. The company’s profit margin is -%, its EBITDA margin is -601.00%, and its revenue ttm is $3.94 Million , which makes it $0.04 revenue per share.

Of the last four earnings reports from Cerecor Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.17 for the next earnings report. Cerecor Inc.’s next earnings report date is 06th May 2021.

The consensus rating of Wall Street analysts for Cerecor Inc. is Moderate Buy (1.67), with a target price of $9, which is +258.57% compared to the current price. The earnings rating for Cerecor Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Cerecor Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Cerecor Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 16.45, ATR14 : 0.30, CCI20 : -161.92, Chaikin Money Flow : -0.25, MACD : -0.24, Money Flow Index : 46.76, ROC : -13.45, RSI : 40.96, STOCH (14,3) : 8.93, STOCH RSI : 0.06, UO : 37.87, Williams %R : -91.07), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Cerecor Inc. in the last 12-months were: Christopher Ryan Sullivan (Buy at a value of $18 336), Garry A. Neil (Buy at a value of $24 593), James A. Harrell (Buy at a value of $79 896), Michael F. Cola (Buy at a value of $250 000)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (66.67 %)
2 (66.67 %)
3 (75.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (33.33 %)
1 (33.33 %)
1 (25.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
1.67
Moderate Buy
1.67
Strong Buy
1.50

Cerecor Inc.

Cerecor Inc is a biopharmaceutical company with commercial operations and research and development capabilities. The Company is building a robust pipeline of innovative therapies in neurology, pediatric healthcare, and orphan rare diseases. The Company is also developing three other neurological clinical and preclinical stage compounds. The Company's pediatric orphan rare disease pipeline is led by CERC-801, CERC-802 and CERC-803. The Company also markets prescription drugs that treat a range of pediatric diseases, disorders and conditions. Cerecor's prescription drugs include Millipred, Ulesfia, Karbinal ER, AcipHex Sprinkle and Cefaclor for Oral Suspension. The Company has marketed medical device, Flexichamber.

CEO: Michael F. Cola

Telephone: +1 410 522-8707

Address: 540 Gaither Road, Rockville 20850, MD, US

Number of employees: 18

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

67%33%

Bearish Bullish

53%47%

Bearish Bullish

55%45%

News

Stocktwits